2-Methoxyestradiol induces apoptosis in cultured human anaplastic thyroid carcinoma cells

Thyroid

Volumn 16, Issue 2, 2006, Pages 143-150

  Roswall, Pernilla ^a   Bu, Shizhong ^b   Rubin, Kristofer ^b   Landström, Maréne ^b   Heldin, Nils Erik ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; CASPASE 3; CASPASE 8; DNA FRAGMENT; M 6383; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

ANAPLASTIC THYROID CARCINOMA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL COUNT; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA DETERMINATION; DRUG EFFECT; ENZYME ACTIVATION; ESTROGEN ACTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; NICK END LABELING; PRIORITY JOURNAL; THYROID CARCINOMA;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA; CASPASE 3; CASPASE 8; CASPASES; CELL LINE, TUMOR; DNA FRAGMENTATION; ESTRADIOL; FLOW CYTOMETRY; G1 PHASE; HUMANS; IN SITU NICK-END LABELING; MAP KINASE SIGNALING SYSTEM; MODELS, STATISTICAL; OSMOSIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RIBONUCLEASES; RNA, MESSENGER; THYROID NEOPLASMS; TIME FACTORS;

EID: 33645462175     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.16.143     Document Type: Article

References (41)

1. Rosai J, Carcangiu ML, DeLellis RA 1992 Tumors of the Thyroid Gland. In: Atlas of the Tumor Pathology. Armed Forces Institute of Pathology, Washington D.C.:, pp. 135-159.
2. Ain KB 1998 Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches. Thyroid 8:715-726.
3. Yeung SC, Xu G, Pan J, Christgen M, Bamiagis A 2000 Manumycin enhances the cytotoxic effect of paclitaxel on anaplastic thyroid carcinoma cells. Cancer Res 60:650-656.
4. Greenberg VL, Williams JM, Cogswell JP, Mendenhall M, Zimmer SG 2001 Histone deacetylase inhibitors promote apoptosis and differential cell cycle arrest in anaplastic thyroid cancer cells. Thyroid 11:315-325.
5. Dziba JM, Marcinek R, Venkataraman C, Robinson JA, Ain KB 2002 Combretastatin A4 phosphate has primary antineoplastic activity against human anaplastic thyroid carcinoma cell lines and xenograft tumors. Thyroid 12:1063-1070.
6. Nagayama Y, Nishihara E, Namba H, Yokoi H, Hasegawa M, Mizuguchi H, Hayakawa T, Hamada H, Yamashita S, Niwa M 2001 Targeting the replication of adenovirus to p53-defective thyroid carcinoma with a p53-regulated Cre/loxP system. Cancer Gene Ther 8:36-44.
7. Iuliano R, Trapasso F, Le Pera I, Schepis P, Sama I, Clodomiro A, Dumon KR, Santoro M, Chiariotti L, Viglietto G, Fusco A 2003 An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo. Cancer Res 63:882-886.
8. Yue TL, Wang X, Louden CS, Gupta S, Pillarisetti K, Gu JL, Hart TK, Lysko PG, Feuerstein GZ 1997 2-Methoxyestradiol, an endogenous es trogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: Possible role for stress-activated protein kinase signaling pathway and Fas expression. Mol Pharmacol 51:951-962.
9. Fotsis T, Zhang Y, Pepper MS, Adlercreutz I-I, Montesano R, Nawroth PP, Schweigerer L 1994 The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368:237-239.
10. Berg D, Sonsalla R, Kuss E 1983 Concentrations of 2-methoxyoestrogens in human serum measured by a heterologous immunoassay with an 1251-labelled ligand. Acta Endocrinol (Copenh) 103:282-288.
11. La Vallee TM, Zhan XFI, Herbstritt CJ, Kough EC, Green SJ, Pribluda VS 2002 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Cancer Res 62:3691-3697.
12. D'Amato RJ, Lin CM, Flynn E, Folkman J, Hamel E 1994 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci USA 91:3964-3968.
13. Qadan LR, Perez-Stable CM, Anderson C, D'Ippolito G, Herron A, Howard CA, Roos BA 2001 2-Methoxyestradiol induces G2/M arrest and apoptosis in prostate cancer. Biochem Biophys Res Commun 285:1259-1266.
14. Lin HL, Liu TY, Chau GY, Lui WY, Chi CW 2000 Comparison of 2-melhoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species. Cancer 89:983-94.
15. Dobos J, Timar J, Bocsi J, Burian Z, Nagy K, Barna G, Petak I, Ladanyi A 2004 In vitro and in vivo antitumor effect of 2-melhoxyestradiol on human melanoma. Int J Cancer 112:771-776.
16. La Vallee TM, Zhan XH, Johnson MS, Herbstritt CJ, Swartz G, Williams MS, Hembrough WA, Green SJ, Pribluda VS 2003 2-methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway. Cancer Res 63:468-475.
17. Dingli D, Timm M, Russell SJ, Witzig TE, Rajkumar SV 2002 Promising preclinical activity of 2-methoxyestradiol in multiple myeloma. Clin Cancer Res 8:3948-3954.
18. Debatin KM 2004 Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother 53:153-159.
19. Chauhan D, Li G, Hideshima T, Podar K, Mitsiades C, Mitsiades N, Munshi N, Kharbanda S, Anderson KC 2003 JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells. J Biol Chem 278:17593-17596.
20. Dahlman T, Lammerts E, Wik M, Bergström JD, Grimelius L, Westermark K, Rubin K, Heldin N-E 2000 Fibrosis in undifferentiated (anaplastic) thyroid carcinomas: evidence for a dual action of tumour cells in collagen type I synthesis. J Pathol 191:376-386.
21. Vindelov LL, Christensen IJ, Nissen NI 1983 A detergent-trypsin method for the preparation of nuclei for How cytometric DNA analysis. Cytometry 3:323-327.
22. Landstrom M, Heldin NE, Bu S, Hermansson A, Itoh S, ten Dijke P, Heldin CH 2000 Smad7 mediates apoptosis induced by transforming growth factor beta in prostatic carcinoma cells. Curr Biol 10:535-538.
23. Chomezynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanatc-phenol-chloroform extraction. Anal Biochem 162:156-159.
24. Bu S, Blaukat A, Fu X, Heldin NE, Landstrom M 2002 Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells. FEBS Lett 531:141-151.
25. Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W 2000 Superoxide dismutase as a target for the selective killing of cancer cells. Nature 407:390-395.
26. Pribluda VS, Gubish ER, Jr., Lavallee TM, Treston A, Swartz GM, Green SJ 2000 2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate. Cancer Metastasis Rev 19:173-179.
27. Seegers JC, Lottering ML, Grobler CJ, van Papendorp DH, Habbersett RC, Shou Y, Lehnert BE 1997 The mammalian metabolite, 2-methoxyestradiol, affects P53 levels and apoptosis induction in transformed cells but not in normal cells. J Steroid Biochem Mol Biol 62:253-267.
28. Wang SH, Myc A, Koenig RJ, Bretz JD, Arscott PL, Baker JR 2000 2-Methoxyestradiol, an endogenous eslrogen metabolite, induces thyroid cell apoptosis. Mol Cell Endocrinol 165:163-172.
29. Shimada K, Nakamura M, Ishida E, Kishi M, Matsuyoshi S, Konishi N 2004 The molecular mechanism of sensitization to Fas-mediated apoptosis by 2-methoxyestradiol in PC3 prostate cancer cells. Mol Carcinog 39:1-9.
30. Lambert C, Apel K, Biesalski HK, Frank J 2004 2-methoxyestradiol induces caspase-independent, mitochondria-centered apoptosis in DS-sarcoma cells. Int J Cancer 108:493-501.
31. Attalla H, Westberg JA, Andersson LC, Adlercreutz H, Makela TP 1998 2-Methoxyestradiol-induced phosphorylation of Bcl-2: uncoupling from JNK/SAPK activation. Biochem Biophys Res Commun 247:616-619.
32. Djavaheri-Mergny M, Wietzerbin J, Besancon F 2003 2-Methoxyestradiol induces apoptosis in Ewing sarcoma cells through mitochondrial hydrogen peroxide production. Oncogene 22:2558-2567.
33. Chang L, Karin M 2001 Mammalian MAP kinase signalling cascades. Nature 410:37-40.
34. Shimada K, Nakamura M, Ishida E, Kishi M, Konishi N 2003 Roles of p3cS- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis. Carcinogenesis 24:1067-1075.
35. Basu A, Haldar S 2003 Identification of a novel Bcl-xL phosphorylation site regulating the sensitivity of taxol- or 2-methoxyestradiol-induced apoptosis. FEBS Lett 538:41-47.
36. Donghi R, Longoni A, Pilotti S, Michieli P, Della Porta G, Pierotti MA 1993 Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J Clin Invest 91:1753-1760.
37. Mukhopadhyay T, Roth JA 1997 Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol. Oncogene 14:379-384.
38. Lakhani NJ, Sarkar MA, Venitz J, Eigg WD 2003 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 23:165-172.
39. Bruno B, Rotta M, Giaccone L, Massaia M, Bertola A, Palumbo A, Boccadoro M 2004 New drugs for treatment of multiple myeloma. Lancet Oncol 5:430-442.
40. Huober JB, Nakamura S, Meyn R, Roth JA, Mukhopadhyay T 2000 Oral administration of an estrogen metabolite-induced potentiation of radiation antitumor effects in presence of wild-type p53 in non-small-cell king cancer. Int J Radiat Oncol Biol Phys 48:1127-1137.
41. Chauhan D, Auclair D, Robinson EK, Hideshima T, Li G, Podar K, Gupta D, Richardson P, Schlossman RL, Krett N, Chen LB, Munshi NC, Anderson KC 2002 Identification of genes regulated by dexamethasone in multiple myeloma cells using oligonucleotide arrays. Oncogene 21:1346-1358.